SCHEMBL13030201

SCHEMBL13030201

c1ccc(-n2c3ccccc3c3cc(-c4cc5c6c(ccc7cc(-c8ccc9c(c8)c8ccccc8n9-c8ccccc8)cc(c76)C5(c5ccc(-n6c7ccccc7c7ccccc76)cc5)c5ccc(-n6c7ccccc7c7ccccc76)cc5)c4)ccc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PTGER4 P35408 1/20 0.34
HDAC4 P56524 1/20 0.33
PTGES O14684 1/20 0.32
KMT2A Q03164 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32
BRCA1 P38398 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TSPO P30536 1/20 0.31
IL1R1 P14778 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13030191 0.96 L3MBTL1 (0.44) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21190566 0.85 L3MBTL1 (0.56) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL17849686 0.84 KDM4E (0.33) KDM4EATML3MBTL1PTGER4PTGES
SCHEMBL26435854 0.83 L3MBTL1 (0.55) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL19420257 0.82 L3MBTL1 (0.53) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL17720813 0.81 KDM4E (0.46) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL20633711 0.81 L3MBTL1 (0.46) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL19238806 0.81 KDM4E (0.46) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL13444287 0.81 L3MBTL1 (0.49) KDM4EATML3MBTL1PTGER4HDAC4
SCHEMBL21190615 0.81 L3MBTL1 (0.51) KDM4EATML3MBTL1PTGER4HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7833635-B2 Organoelectroluminescent compound and organoelectroluminescent device employing the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2010-11-16 US disclosed
US-7833635-B2 Organoelectroluminescent compound and organoelectroluminescent device employing the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2010-11-16 US disclosed
US-20080093987-A1 Organoelectroluminescent compound and organoelectroluminescent device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2008-04-24 US disclosed
US-20080093987-A1 Organoelectroluminescent compound and organoelectroluminescent device employing the same SAMSUNG DISPLAY CO., LTD. (KR) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080093987-A1 Organoelectroluminescent compound and organoelectroluminescent device employing the same PPOX, EML4, ALPL KDM4E 2958/4885ATM 4601/4885L3MBTL1 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.